You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

neoantigen

Showing 201 - 213 of 213
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kidney Transplantation Trial in United States (DT, Daclizumab, KLH)

Completed
Has Results
  • Kidney Transplantation
  • DT
  • +2 more
  • Los Angeles, California
  • +4 more
Dec 9, 2015

Multiple Myeloma Trial run by the NCI (Myeloma Immunoglobulin Idiotype Vaccine, Bortezomib, Cyclophosphamide)

Completed
Has Results
  • Multiple Myeloma
  • Myeloma Immunoglobulin Idiotype Vaccine
  • +11 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 19, 2017

Relapsing Forms of Multiple Sclerosis Trial in United States (dimethyl fumarate, tetanus diphtheria toxoids vaccine, 23-valent

Completed
Has Results
  • Relapsing Forms of Multiple Sclerosis
  • dimethyl fumarate
  • +4 more
  • Gilbert, Arizona
  • +13 more
May 1, 2017

Leukemia, Acute Myelogenous (AML), Leukemia, Acute Lymphocytic (ALL), Leukemia, Chronic Myelogenous (CML) Trial run by the NCI

Completed
Has Results
  • Leukemia, Acute Myelogenous (AML)
  • +4 more
  • WT1 Peptide-Pulsed Dendritic Cells
  • +7 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 1, 2017

Stage IV Melanoma Trial in Louisville (A-dmDT390-bisFv(UCHT1), Pembrolizumab, Ionizing Radiation)

Unknown status
  • Stage IV Melanoma
  • A-dmDT390-bisFv(UCHT1)
  • +2 more
  • Louisville, Kentucky
    James Graham Brown Cancer Center
Dec 12, 2016

Asthma, Lung Diseases Trial (nedocromil budesonide)

Completed
  • Asthma
  • Lung Diseases
  • nedocromil budesonide
  • (no location specified)
Jan 14, 2016

Dermatitis Trial in Cambridge (KLH 0.1 mg, KLH 5 mg, PBS (0.1 mL))

Completed
  • Dermatitis
  • KLH 0.1 mg
  • +3 more
  • Cambridge, United Kingdom
    GSK Investigational Site
May 12, 2017

Definition ofImmune Signature Predictive of Anti-PD1 Antibody in

Unknown status
  • Malignant Melanoma
  • Biopsies
  • (no location specified)
Oct 24, 2016

HCV Infection Trial in Worldwide (GS-9450, Placebo)

Terminated
  • HCV Infection
  • Phoenix, Arizona
  • +72 more
Jan 3, 2014

Primary Immune Deficiency Diseases Trial in St. Petersburg (Bacteriophage OX174)

Unknown status
  • Primary Immune Deficiency Diseases
  • Bacteriophage OX174
  • St. Petersburg, Florida
    University of South Florida
Jul 16, 2012

HIV Trial in Australia, United States (Tetanus Toxoid Vaccine, Indinavir sulfate, Lamivudine/Zidovudine)

Completed
  • HIV Infections
  • Tetanus Toxoid Vaccine
  • +9 more
  • San Francisco, California
  • +11 more
Mar 1, 2011

HIV Trial in Puerto Rico, United States (Hepatitis A Vaccine (Inactivated))

Completed
  • HIV Infections
  • Hepatitis A Vaccine (Inactivated)
  • Birmingham, Alabama
  • +49 more
Mar 1, 2011

Thrombocytopenia Trial in France (Pathogen Reduction Technology)

Completed
  • Thrombocytopenia
  • Pathogen Reduction Technology
  • Besançon, France
  • +9 more
Oct 6, 2009